Skip to content

Trial Summary

A surveillance study investigating whole body magnetic resonance imaging and other diagnostic procedures in people at high risk of cancer

Acronym:

SMOC+

ACTRN/NCT /ethics:

ACTRN12613000987763

Scientific title:

A surveillance study utilizing whole body magnetic resonance imaging and other surveillance procedures in people with germ line cancer gene mutations to investigate the prevalence and incidence of investigable lesions.

Sponsor / Cooperative group:

ASS/Garvan

Trial & Patient Characteristics

Cancer TypeAll cancers
Trial TypeEarly detection, diagnosis, prognosis
Phase-
Age Range18 years and older
SexBoth
Tumour Stream -
Cancer Stage-
Anticipated Start Date2013-06-09
Anticipated End Date2022-09-01

Participating Hospitals

HospitalRoyal Adelaide Hospital
Clinical Trial CoordinatorAnne Milton
Emailanne.milton@sa.gov.au
Phone08 7074 2342
Principal InvestigatorProfessor Michael Brown
Recruitment StatusRecruiting